Prospects for the use of CAR-T-cell therapy in breast cancer: A look into the future
Authors:
Open Access
- 22 March 2025
- journal article
- Published by Society for Regenerative Medicine in Регенерация органов и тканей
- Vol. 2 (2) , 10-23
Abstract
Cellular immunotherapy CAR-T (Chimeric Antigen Receptor T-Cell, or T-cells with a chimeric antigen receptor) is an advanced approach to the treatment of oncological diseases. Currently, CAR-Ttherapy has shown high efficiency in the treatment of oncohematological diseases. At the same time, numerous attempts to create CAR-T-constructs for the treatment of solid tumors, in particular breast cancer (BC), have not demonstrated significant clinical efficacy. It is assumed that the key to solving these problems lies in the development and implementation of new genetic engineering strategies.The purpose of this review was to summarize and systematize existing studies with CAR technology. In this paper, we summarize potential targets for the treatment of BC, detail the existing limitations of using these technologies and identify important future trends in this area.Keywords
This publication has 59 references indexed in Scilit:
- Recent advancement in breast cancer treatment using CAR T cell therapy:- A reviewAdvances in Cancer Biology - Metastasis, 2023
- CD27 enhances the killing effect of CAR T cells targeting trophoblast cell surface antigen 2 in the treatment of solid tumorsCancer Immunology, Immunotherapy, 2021
- Side-effect management of chimeric antigen receptor (CAR) T-cell therapyAnnals of Oncology, 2021
- Breast cancer: Biology, biomarkers, and treatmentsInternational Immunopharmacology, 2020
- Solid Tumors Challenges and New Insights of CAR T Cell EngineeringStem Cell Reviews and Reports, 2019
- Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancerBreast Cancer Research and Treatment, 2018
- The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer ProgressionCell Reports, 2018
- Folate Receptor Alpha Expression Is Associated With Increased Risk of Recurrence in Triple-negative Breast CancerClinical Breast Cancer, 2017
- Increasing the safety and efficacy of chimeric antigen receptor T cell therapyProtein & Cell, 2017
- Engineering anti‐GD2 monoclonal antibodies for cancer immunotherapyFEBS Letters, 2013